Cases, and somewhat more ominously, deaths are ramping up in Bahrain, one of the most vaccinated countries on earth:
The country relied heavily on the Sinopharm inactivated vaccine, which apparently puts it at greater risk for future reinfection. Along with nearby United Arab Emirates, Bahrain is offering people who did not get a good antibody response a third dose of the vaccine, which is highly suggestive. A recent Chilean study cited by the British Medical Journal claims Sinopharm's jab was only 3% effective after the first dose, with higher figures after the second. Given the sketchy data surrounding Sinopharm's vaccine, it's not a surprise we're seeing irregularities like this.
No comments:
Post a Comment